NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/23/2024
Back to search
Official data from USPTO
PAPIVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
04/23/2024
Trademark type
Combined
Nice classes
42
Filing date
01/18/2023
Registration date
04/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/23/2024
Last transaction
04/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/29/2021
First use in commerce
09/29/2021
Drawing code
3
Owner type
03
Owner location
Taipei City, TW
Examiner
SINGH, TEJBIR
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized wording "PapiVax". On the left, there is a globe with rings and orbits and three viruses made up of nine groups of parallel lines, two incomplete circles, and wavy outline.
Holders and representatives
Holders
PAPIVAX BIOTECH INC.
Representatives
Zhirong Liu
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Bacteriological research; Biochemical research and development; Biological research; Biotechnology research; Chemical analysis; Chemical analysis services; Chemical research; Chemist services; Consulting services for others in the field of designplanningimplementation project management of pharmaceutical trials and clinical trials; Consulting services in the field of industrial engineering; Cosmetics research for others; Culturing of cells for others for scientific research purposes; Custom design and development of chemical reagents and biochemical assays; Medical research; Pharmaceutical research services; Product quality evaluation; Product quality testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Rental of laboratory apparatus and instruments; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of vaccines and medicines; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific laboratory services; Scientific research; Technical consulting in the field of pharmaceutical studies; Technical writing
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2024
PUBO
PUBLISHED FOR OPPOSITION
02/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2023
GNRT
NON-FINAL ACTION E-MAILED
10/16/2023
CNRT
NON-FINAL ACTION WRITTEN
10/16/2023
DOCK
ASSIGNED TO EXAMINER
10/16/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/17/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/16/2023
NWAP
NEW APPLICATION ENTERED
01/21/2023
Continuous trademark protection
Get notified about every new filing that threatens PAPIVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.